Derrick Sung

Derrick Sung

Director of Finance/CFO at PULMONX CORPORATION

Net worth: 223 276 $ as of 31/05/2026

53 year
Health Technology
Consumer Services
Finance

Profile

Derrick Sung is currently Director at Sensydia Corp.
since 2018, Chief Financial Officer at Aerin Medical, Inc. since 2023, and Chief Operating & Financial Officer at Pulmonx Corp.
starting in 2025.
Former roles include Independent Director at Minerva Surgical, Inc. from 2022 to 2024, Chief Financial & Accounting Officer at Pulmonx Corp.
from 2019 to 2023, Executive VP-Strategy & Corporate Development at iRhythm Technologies, Inc. from 2015 to 2019, Senior Research Analyst at Sanford C.
Bernstein & Co. LLC from 2008 to 2014, Director-Marketing & Business Development at Boston Scientific Corp.
from 2004 to 2008, Principal at The Boston Consulting Group, Inc. from 2000 to 2004, and Principal at Vascular Intervention.
Education includes undergraduate studies at Stanford University, an MBA from San Diego State University, and a doctorate from the University of California San Diego.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/03/2026 135,319 ( 0.32% ) 223 276 $ 31/05/2026

Derrick Sung active positions

CompaniesPositionStart
PULMONX CORPORATION Director of Finance/CFO 03/11/2025
Director of Finance/CFO 20/11/2023
Director/Board Member 01/08/2018

Former positions of Derrick Sung

CompaniesPositionEnd
MINERVA SURGICAL, INC. Director/Board Member 01/01/2024
PULMONX CORPORATION Director of Finance/CFO 10/10/2023
IRHYTHM HOLDINGS, INC. Corporate Officer/Principal 01/05/2019
BOSTON SCIENTIFIC CORPORATION Sales & Marketing 01/01/2008
Corporate Officer/Principal 01/01/2004
See the detail of Derrick Sung's experience

Training of Derrick Sung

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

72

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Finance

Consumer Services

Consumer Services

Vascular Intervention

Finance

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!